Introduction:
Diabetic peripheral neuropathy (DPN) is the result of nerve damage in the toes, feet, or hands, causing loss of feeling or pain for up to 50% of patients. The purpose of this qualitative study was to assess the burden and impact of DPN pain (DPNP) symptoms on patient's functioning and well-being.
Methods:
Four focus groups and 47 telephone interviews were conducted to understand the experience and impacts of DPNP from the patient's perspective. All participants were over the age of 18 years, read/spoke English, had a documented diagnosis of DPNP with symptoms for 6 months and a minimum 12-month history of diabetes mellitus, and had a daily pain rating of at least 4 on an 11-point numerical rating scale. Interview transcripts were analyzed thematically based on modified grounded theory principles.
Results:
There were 70 respondents--48 (68.6%) males and 22 (31.4%) females. The mean age was 54.0 years (range 26-70), and nearly all respondents had type 2 diabetes (87%). Analysis identified four major areas of impact; DPNP patients reported difficulties with: (1) physical function, i.e. walking, exercise, energy, standing, balance, bending, and mobility; (2) daily life, i.e. productivity, recreational activities, work, enjoyment, focus, and chores; (3) social/psychological, i.e. anxiety, friends/family, irritability, depression, and fear; and (4) sleep, i.e. sleep, falling asleep, waking in the night, returning to sleep, and not feeling rested upon awakening.
Conclusion:
DPNP is a significant complication of diabetes with multiple impacts for patient functioning and well-being, which increase the burden of disease.
Citing Articles
Mapping the Journey of Patients with Painful Diabetic Peripheral Neuropathy in the Philippines.
Espiritu-Picar R, Matawaran B, Lim J, Ratnasingham P
Acta Med Philipp. 2024; 57(6):46-51.
PMID: 39483691
PMC: 11522588.
DOI: 10.47895/amp.vi0.4471.
A novel proprioceptive rehabilitation program: A pilot randomized controlled trail as an approach to address proprioceptive deficits in patients with diabetic polyneuropathy.
Malwanage K, Liyanage E, Weerasinghe V, Antonypillai C, Nanayakkara I
PLoS One. 2024; 19(7):e0305055.
PMID: 38968315
PMC: 11226081.
DOI: 10.1371/journal.pone.0305055.
Balance performance, falls-efficacy and social participation in patients with type 2 diabetes mellitus with and without vestibular dysfunction.
Komalasari D, Vongsirinavarat M, Hiengkaew V, Nualnim N
PeerJ. 2024; 12:e17287.
PMID: 38766481
PMC: 11102735.
DOI: 10.7717/peerj.17287.
Novel Mechanism for Memantine in Attenuating Diabetic Neuropathic Pain in Mice via Downregulating the Spinal HMGB1/TRL4/NF-kB Inflammatory Axis.
Alomar S, Abo El Gheit R, Enan E, El-Bayoumi K, Shoaeir M, Elkazaz A
Pharmaceuticals (Basel). 2021; 14(4).
PMID: 33915770
PMC: 8065430.
DOI: 10.3390/ph14040307.
Wearable Focal Muscle Vibration on Pain, Balance, Mobility, and Sensation in Individuals with Diabetic Peripheral Neuropathy: A Pilot Study.
Chandrashekhar R, Wang H, Dionne C, James S, Burzycki J
Int J Environ Res Public Health. 2021; 18(5).
PMID: 33801216
PMC: 7967773.
DOI: 10.3390/ijerph18052415.
"It Gave Me Hope" Experiences of Diverse Safety Net Patients in a Group Acupuncture Intervention for Painful Diabetic Neuropathy.
Liu R, Santana T, Schillinger D, Hecht F, Chao M
Health Equity. 2020; 4(1):225-231.
PMID: 32462104
PMC: 7247034.
DOI: 10.1089/heq.2020.0004.
A gain-of-function sodium channel β2-subunit mutation in painful diabetic neuropathy.
Alsaloum M, Estacion M, Almomani R, Gerrits M, Bonhof G, Ziegler D
Mol Pain. 2019; 15:1744806919849802.
PMID: 31041876
PMC: 6510061.
DOI: 10.1177/1744806919849802.
Evaluation of composite responder outcomes of pain intensity and physical function in neuropathic pain clinical trials: an ACTTION individual patient data analysis.
Patel K, Allen R, Burke L, Farrar J, Gewandter J, Gilron I
Pain. 2018; 159(11):2245-2254.
PMID: 30001225
PMC: 7184787.
DOI: 10.1097/j.pain.0000000000001324.
Pain Experience in Hemophilia Patients: A Hermeneutic Phenomenological Study.
Rambod PhD M, Sharif PhD F, Molazem PhD Z, Khair PhD K
Int J Community Based Nurs Midwifery. 2016; 4(4):309-319.
PMID: 27713894
PMC: 5045975.
Synthesis, solubility, plasma stability, and pharmacological evaluation of novel sulfonylhydrazones designed as anti-diabetic agents.
Zapata-Sudo G, da Costa Nunes I, Araujo J, Silva J, Trachez M, da Silva T
Drug Des Devel Ther. 2016; 10:2869-2879.
PMID: 27672310
PMC: 5024769.
DOI: 10.2147/DDDT.S108327.
The Emerging Role of HMGB1 in Neuropathic Pain: A Potential Therapeutic Target for Neuroinflammation.
Wan W, Cao L, Khanabdali R, Kalionis B, Tai X, Xia S
J Immunol Res. 2016; 2016:6430423.
PMID: 27294160
PMC: 4887637.
DOI: 10.1155/2016/6430423.
Physiological and psychological challenges of increasing physical activity and exercise in patients at risk of diabetic foot ulcers: a critical review.
Crews R, Schneider K, Yalla S, Reeves N, Vileikyte L
Diabetes Metab Res Rev. 2016; 32(8):791-804.
PMID: 27155091
PMC: 5466070.
DOI: 10.1002/dmrr.2817.
Development and validation of the Diabetic Peripheral Neuropathic Pain Impact (DPNPI) measure, a patient-reported outcome measure.
Brod M, Blum S, Bushnell D, Ramasamy A
Qual Life Res. 2015; 24(12):3001-14.
PMID: 26068732
DOI: 10.1007/s11136-015-1037-0.